about
Heart failure across Asia: Same healthcare burden but differences in organization of careDecongestion: Diuretics and other therapies for hospitalized heart failureIndividual patient data network meta-analysis of mortality effects of implantable cardiac devicesThe importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trialsThe diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care settingExpert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failureThe heart failure epidemic: a UK perspectiveImpact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies.Atrial fibrillation: improvement in identification and stroke preventive therapy - data from the UK Clinical Practice Research Datalink, 2000-2012.The use of hospital admission data as a measure of outcome in clinical studies of heart failure.Analyzing Health-Related Quality of Life Data to Estimate Parameters for Cost-Effectiveness Models: An Example Using Longitudinal EQ-5D Data from the SHIFT Randomized Controlled Trial.Prediction and prevention of sudden cardiac death in heart failure.Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK.The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.Management of chronic heart failure.New pacing technologies for heart failure.The cost effectiveness of ivabradine in the treatment of chronic heart failure from the U.K. National Health Service perspective.Quantifying the added value of BNP in suspected heart failure in general practice: an individual patient data meta-analysis.Current and future technologies for remote monitoring in cardiology and evidence from trial data.The epidemiological features of heart failure in developing countries: a review of the literature.Incidence and outcome of persons with a clinical diagnosis of heart failure in a general practice population of 696,884 in the United Kingdom.Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptomsBuilding consensus for provision of breathlessness rehabilitation for patients with chronic obstructive pulmonary disease and chronic heart failure.The continuum of personalized cardiovascular medicine: a position paper of the European Society of CardiologyUK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database.Clinical applications of B-type natriuretic peptide (BNP) testing.Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.Survival of patients with a new diagnosis of heart failure: a population based studyEpidemiology and clinical aspects of congestive heart failure.N-terminal brain natriuretic peptide and subsequent hospital admission for worsening heart failure.Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial.Gender and heart failure: a population perspectiveCardiovascular risk: a UK priority--it's time to act II.Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy.Identification and guided treatment of ventricular dysfunction in general practice using blood B-type natriuretic peptide.Cost-Effectiveness of Ivabradine for Heart Failure in the United StatesUse of hospital services by age and comorbidity after an index heart failure admission in England: an observational study.The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failureA randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study.
P50
Q26740285-15EA8C71-024C-4A66-9731-273717990457Q26750884-83B795FD-80CD-4A91-8ADE-63A2AC0B0BC6Q26798319-84154878-E1EE-435C-AF46-673815EEF0DDQ27009483-C25726AD-731D-45D6-B6D1-A60F4B97A46BQ28084405-D61790FB-0537-46B2-BC45-CA5352E7D403Q29994549-D3DFB7B9-B0DD-433E-BC9C-57ED4F5D20D0Q30235952-612A2F0B-0919-4B05-8AFB-5F964FFFFB07Q30251913-F44A72D5-23CC-477D-B19F-63C7F1E7134CQ30725857-FD3E77EB-1608-4F8D-8DFB-235217AF244CQ30765315-33604940-1F02-4BF6-AA54-513D49933ECBQ31162392-12584174-9DFC-4D33-AFC1-C47B0D972AA4Q33152534-408475B7-52B1-41BD-BD30-9ECF5B185A6EQ33479924-C61BB152-274F-42F9-8A8A-7CE8ECF8C68EQ33697820-86591784-3C1D-42DF-89D3-2E8B8471B0BAQ33811699-3659A363-576F-4D64-A63A-A078DE55BE46Q33815045-7C166558-B083-4E4F-90D4-5937464056FEQ33834583-017D39CA-748F-4ADD-841D-A15489B5C436Q33866831-952678B6-9279-4B50-A005-FA162D452ED6Q34285229-324AA7D2-FB10-46EE-9E84-23FAB12E281BQ34386078-BABAA6EC-828C-403D-9016-A1FF5E544178Q34395504-F4E7B79E-509D-4A40-BD78-4DCED0FD709BQ34431326-334C7732-B00B-4ADB-BBC6-24390231C62FQ34521930-75B69972-7ED9-4BA6-8B16-8A99F7F82768Q34644992-8EA87542-880D-4B60-9716-A944BD0C9651Q35536185-A7D6946D-BC56-43FA-9A77-C0E1FBFA54E1Q35548836-594B7241-3708-4670-A913-860CBA3F5141Q35555062-D7F6373C-6612-45AE-9536-1FCA4033CF83Q35566720-E90E8CC6-9B91-43F5-8038-D56076316D18Q35580122-E4D964CC-7A16-440E-808E-C7EF7ADBE5E5Q35583858-0466E3B1-F177-4F53-A144-B1540A9F46F2Q35762717-581578F4-1872-4C74-A066-C12F3A097B9AQ35771154-AA64249B-55C1-41B0-80A1-B7ED4B68E648Q35808155-A00D4924-5539-4816-8226-7EAEE7B7803CQ35841464-055C9CAE-A0F9-4415-A792-3E03837A4E50Q36166456-70335BB5-0B22-4461-A9E0-B66F39A1D2C1Q36707626-A6045D4A-DD15-4DC6-8DF0-152464F588BAQ36956750-85207D17-6A24-4DC0-AAC7-FDE8C29C8799Q37007173-889453D5-782A-481E-A77F-B22236481448Q37081687-4AC90E7B-5512-4091-A277-9CA8BC63BF49Q37102983-6A2BCE15-5CB2-4FAF-ABE7-1A2967FDEB5E
P50
description
hulumtues
@sq
investigador
@pt
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Martin Cowie
@ast
Martin Cowie
@en
Martin Cowie
@es
Martin Cowie
@nl
Martin Cowie
@pt
Martin Cowie
@sl
type
label
Martin Cowie
@ast
Martin Cowie
@en
Martin Cowie
@es
Martin Cowie
@nl
Martin Cowie
@pt
Martin Cowie
@sl
prefLabel
Martin Cowie
@ast
Martin Cowie
@en
Martin Cowie
@es
Martin Cowie
@nl
Martin Cowie
@pt
Martin Cowie
@sl
P1006
P214
P244
P1006
P106
P21
P213
0000 0001 1511 739X
P214
P244
nr2003040237
P31
P496
0000-0001-7457-2552
P735
P7859
lccn-nr2003040237